Genzyme Rejects Sanofi-Aventis Takeover Bid

Genzyme, which makes drugs to treat leukemia and multiple sclerosis, has rejected a hostile takeover bid from French drugmaker Sanofi-Aventis. The offer “dramatically undervalues” Genzyme, the company said Friday, putting its v…

Report: AOL Preparing Possible Yahoo Takeover Bid

AOL is reported to be collaborating with private equity firms to explore a possible Yahoo takeover attempt. In theory, an AOL-Yahoo deal would position the merged company to compete for online advertising dollars more effective…

Sara Lee Shares Soar on Reports it Spurned KKR Offer

Food giant Sara Lee saw its shares surge over 18% in premarket trading Monday after the New York Post reported the company turned down a $12 billion buyout offer from private-equity company KKR & Co.), citing unnamed sources.
…

Sanofi Is in No Rush to Reach Deal With Genzyme

Sanofi-Aventis CEO Chris Viehbacher said Wednesday that he believes his French pharmaceutical company will eventually buy U.S. biotech company Genzyme at a reasonable price. However, he expects it will take some time to agree o…